Daniel Molnar is a Global Health Economics & Payer Evidence Director at AstraZeneca, where they currently lead initiatives focused on health economics and market access. With 15 years of experience, they have worked extensively in evidence generation for both global vaccines and local market access, dedicating eight years to global vaccine projects and seven years to local market strategies. Previously, at GSK, Daniel directed evidence generation activities for RSV in older adults and built a team to support diverse health initiatives. Daniel has collaborated with various stakeholders to shape study protocols and strategies, demonstrating a strong commitment to patient-focused medicine development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices